Delta‐NT or NT MoM: which is the most appropriate method for calculating accurate patient‐specific risks for trisomy 21 in the first trimester?
Open Access
- 7 July 2003
- journal article
- research article
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 22 (2) , 142-148
- https://doi.org/10.1002/uog.186
Abstract
Objective To assess whether in screening for trisomy 21 by nuchal translucency (NT) the delta or the multiples of the median (MoM) approach is the most appropriate method for calculating accurate individual patient-specific risks. Methods Data on fetal NT and crown–rump length from 128 030 unaffected and 428 trisomy 21 pregnancies, measured by sonographers who had obtained The Fetal Medicine Foundation Certificate of Competence in the 11–14-Week Scan, were used. We examined first, if the distribution of NT MoM and log10(NT MoM) was Gaussian; second, if the standard deviation of the distributions did not change with gestation; and third, if the median MoM in the affected population was a constant proportion of the median for unaffected pregnancies. All of these features are required to underpin the MoM approach. NT distributions and those of delta-NT were also analyzed. A non-parametric kernel density method was then used to assess the validity of both methods. Errors in the estimation of individual patient-specific risks using the MoM approach were assessed. Results In the unaffected pregnancies, the distributions of NT MoM and log10(NT MoM) were not Gaussian and the standard deviation of log10(NT MoM) decreased with gestation. In the trisomy 21 pregnancies, the median NT MoM decreased significantly with gestation, whereas the median delta-NT did not change with gestation. The non-parametric density approach showed that contours of constant likelihood ratio were parallel to the gestational age-dependent median NT values, thus supporting the delta-NT approach. The NT MoM approach resulted in women being given an overestimate of risk for trisomy at 11 weeks and a considerable underestimate of risk at 13 weeks. Conclusion In the calculation of risk for trisomy 21 by NT the NT MoM approach is inaccurate and inappropriate because the underlying assumptions are not valid. In contrast, the delta-NT approach gives accurate estimates of risks. Copyright © 2003 ISUOG. Published by John Wiley & Sons, Ltd.Keywords
This publication has 14 references indexed in Scilit:
- Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one‐stop clinic: a review of three years prospective experienceBJOG: An International Journal of Obstetrics and Gynaecology, 2003
- One‐stop clinic for assessment of risk for trisomy 21 at 11–14 weeks: a prospective study of 15 030 pregnanciesUltrasound in Obstetrics & Gynecology, 2002
- Combined ultrasound and biochemical screening for Down's Syndrome in the first trimester: a Scottish multicentre studyBJOG: An International Journal of Obstetrics and Gynaecology, 2002
- Maternal age‐ and gestation‐specific risk for trisomy 21Ultrasound in Obstetrics & Gynecology, 1999
- Combining Ultrasound and Biochemistry in First-Trimester Screening for Down's syndromePrenatal Diagnosis, 1997
- Comparison between two methods of standardization for gestational age differences in fetal nuchal translucency measurement in first-trimester screening for trisomy 21Ultrasound in Obstetrics & Gynecology, 1997
- Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestationBJOG: An International Journal of Obstetrics and Gynaecology, 1995
- Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy.BMJ, 1992
- The use of cusums and other techniques in modelling continuous covariates in logistic regressionStatistics in Medicine, 1992
- Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha‐fetoprotein levelBJOG: An International Journal of Obstetrics and Gynaecology, 1987